Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins

Genome Research

Volumn 25, Issue 6, 2015, Pages 858-871

  Wang, Eric T ^a   Ward, Amanda J ^a,b   Cherone, Jennifer M ^a   Giudice, Jimena ^b   Wang, Thomas T ^a,c   Treacy, Daniel J ^a   Lambert, Nicole J ^a   Freese, Peter ^a   Saxena, Tanvi ^a   Cooper, Thomas A ^b   Burge, Christopher B ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN CELF1; PROTEIN CELF2; PROTEIN MBNL1; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; CELF PROTEIN; CELF1 PROTEIN; CELF1 PROTEIN, HUMAN; CELF2 PROTEIN, HUMAN; ISOPROTEIN; MBNL1 PROTEIN, HUMAN; MBNL2 PROTEIN, HUMAN; NERVE PROTEIN; TRANSCRIPTOME;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; EXON; GENE EXPRESSION; GENE REPRESSION; HEART DEVELOPMENT; HEART MUSCLE; IMMUNOPRECIPITATION; INTRON; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA BINDING; RNA SEQUENCE; RNA SPLICING; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HEART; HUMAN; METABOLISM; MYOTONIC DYSTROPHY; PHYSIOLOGY; SEQUENCE ANALYSIS; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALS; CELF PROTEINS; CELF1 PROTEIN; DOWN-REGULATION; EXONS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HUMANS; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MYOTONIC DYSTROPHY; NERVE TISSUE PROTEINS; PROTEIN ISOFORMS; RNA SPLICING; RNA, MESSENGER; RNA-BINDING PROTEINS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84931829028     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.184390.114     Document Type: Article

References (58)

1. Adereth Y, Dammai V, Kose N, Li R, Hsu T. 2005. RNA-dependent integrin α3 protein localization regulated by the Muscleblind-like protein MLP1. Nat Cell Biol 7: 1240-1247.
2. Andelfinger G, Tapper AR, Welch RC, Vanoye RC, Vanoye CG, George AL Jr, Benson DW. 2002. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 71: 663-668.
3. Barreau C, Paillard L, Mereau A, Osborne HB. 2006. Mammalian CELF/Bruno-like RNA-binding proteins: molecular characteristics and biological functions. Biochimie 88: 515-525.
4. Birk E, Har-Zahav A, Manzini CM, Pasmanik-Chor M, Kornreich L, Walsh CA, Noben-Trauth K, Albin A, Simon AJ, Colleaux L, et al. 2010. SOBPismutated insyndromic and nonsyndromic intellectual disability and is highly expressed in the brain limbic system. Am J Hum Genet 87: 694-700.
5. Charlet BN, Logan P, Singh G, Cooper TA. 2002. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol Cell 9: 649-658.
6. Dasgupta T, Ladd AN. 2012.The importanceof CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins. Wiley Interdiscip Rev RNA 3: 104-121.
7. Dembowski JA, Grabowski PJ. 2009. The CUGBP2 splicing factor regulates an ensemble ofbranchpoints from perimeter binding sites with implications for autoregulation. PLoS Genet 5: e1000595.
8. Dhaenens CM, Schraen-Maschke S, Tran H, Vingtdeux V, Ghanem D, Leroy O, Delplanque J, Vanbrussel E, Delacourte A, Vermersch P, et al. 2008. Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats. Exp Neurol 210: 467-478.
9. Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, Donohue JP, Hall MP, Shiue L, Swanson MS, Thornton CA, et al. 2010. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol 17: 187-193.
10. Faustino NA, Cooper TA. 2005. Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment. Mol Cell Biol 25: 879-887.
11. Giudice J, Xia Z, Wang ET, Scavuzzo MA, Ward AJ, Kalsotra A, Wang W, Wehrens XH, Burge CB, Li W, et al. 2014. Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development. Nat Commun 5: 3603.
12. Goers ES, Purcell J, Voelker RB, Gates DP, Berglund JA. 2010. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing. Nucleic Acids Res 38: 2467-2484.
13. Goo YH, Cooper TA. 2009. CUGBP2 directly interacts with U2 17S snRNP components and promotes U2 snRNA binding to cardiac troponin T pre-mRNA. Nucleic Acids Res 37: 4275-4286.
14. Hafner M, Landgraf P, Ludwig J, Rice A, Ojo T, Lin C, Holoch D, Lim C, Tuschl T. 2008. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 44: 3-12.
15. Han J, Cooper TA. 2005. Identification of CELF splicing activation and repression domains in vivo. Nucleic Acids Res 33: 2769-2780.
16. Ho TH, Charlet BN, Poulos MG, Singh G, Swanson MS, Cooper TA. 2004. Muscleblind proteins regulate alternative splicing. EMBO J 23: 3103-3112.
17. Ho TH, Savkur RS, Poulos MG, Mancini MA, Swanson MS, Cooper TA. 2005. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J Cell Sci 118: 2923-2933.
18. Izquierdo JM, Majos N, Bonnal S, Martinez C, Castelo R, Guigo R, Bilbao D, Valcarcel J. 2005. Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol Cell 19: 475-484.
19. ′ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc Natl Acad Sci 106: 7028-7033.
20. Kalsotra A, Xiao X, Ward AJ, Castle JC, Johnson JM, Burge CB, Cooper TA. 2008. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci 105: 20333-20338.
21. Kalsotra A, Wang K, Li PF, Cooper TA. 2010. MicroRNAs coordinatean alternative splicing network during mouse postnatal heart development. Genes Dev 24: 653-658.
22. KalsotraA, Singh RK, GurhaP, Ward AJ, Creighton CJ, Cooper TA. 2014. The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression. Cell Rep 6: 336-345.
23. Katz Y, Wang ET, Airoldi EM, Burge CB. 2010. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 7: 1009-1015.
24. KishoreS, Jaskiewicz L, Burger L, Hausser J, Khorshid M, Zavolan M. 2011. A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nat Methods 8: 559-564.
25. Koshelev M, Sarma S, Price RE, Wehrens XHT, Cooper TA. 2010. Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1. Hum Mol Genet 19: 1066-1075.
26. Kuyumcu-Martinez NM, Wang GS, Cooper TA. 2007. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 28: 68-78.
27. Ladd AN. 2013. CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease. Mol Cell Neurosci 56: 456-464.
28. Ladd AN, Stenberg MG, Swanson MS, Cooper TA. 2005. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev Dyn 233: 783-793.
29. Lambert N, Robertson A, Jangi M, McGeary S, Sharp PA, Burge CB. 2014. RNA Bind-n-Seq: quantitative assessment ofthe sequence and structural binding specificity of RNA binding proteins. Mol Cell 54: 887-900.
30. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
31. Lee JE, Lee JY, Wilusz J, Tian B, Wilusz CJ. 2010. Systematic analysis of cis-elements in unstable mRNAs demonstrates that CUGBP1 is a key regulator of mRNA decay in muscle cells. PLoS One 5: e11201.
32. Li N, YouX, ChenT, Mackowiak SD, Friedlander MR, WeigtM, DuH, Gogol-Doring A, Chang Z, Dieterich C, et al. 2013. Global profiling of miRNAs and the hairpin precursors: insights into miRNA processing and novel miRNA discovery. Nucleic Acids Res 41: 3619-3634.
33. LinX, Miller JW, MankodiA, Kanadia RN, Yuan Y, Moxley RT, Swanson MS, Thornton CA. 2006. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 15: 2087-2097.
34. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, et al. 1997. Changes in gene expression in the intact human heart: downregulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 100: 2315-2324.
35. Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, Cannon SC, Thornton CA. 2002. Expanded CUG repeats trigger aberrant splicingof ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10: 35-44.
36. Marquis J, Paillard L, Audic Y, Cosson B, Danos O, Le Bec C, Osborne HB. 2006. CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding. Biochem J 400: 291-301.
37. ′ UTRs and facilitate mRNA decay. Sci Rep 2: 209.
38. Matlin AJ, Clark F, Smith CWJ. 2005.Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol 6: 386-398.
39. Moraes JC, Amaral ME, Picardi PK, Calegari VC, Romanatto T, Bermudez-Echeverry M, Chiavegatto S, Saad MJ, Velloso LA. 2006. Inducible-NOS but not neuronal-NOS participate in the acute effect of TNF-α on hypothalamic insulin-dependent inhibition of food intake. FEBS Lett 580: 4625-4631.
40. Paillard L, Legagneux V, Beverley Osborne H. 2003. A functional deadeny-lation assay identifies human CUG-BP as a deadenylation factor. Biol Cell 95: 107-113.
41. Philips AV, Timchenko LT, Cooper TA. 1998. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280: 737-741.
42. Raj B, Irimia M, Braunschweig U, Sterne-Weiler T, O'Hanlon D, Lin ZY, Chen GI, Easton LE, Ule J, Gingras AC, et al. 2014. A global regulatory mechanism for activating an exon network required for neurogenesis. Mol Cell 56: 90-103.
43. Rattenbacher B, Beisang D, Wiesner DL, Jeschke JC, von Hohenberg M, St Louis-Vlasova IA, Bohjanen PR. 2010. Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay. Mol Cell Biol 30: 3970-3980.
44. Robinson MD, Oshlack A. 2010. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 11: R25.
45. ′ splice site-dependent assembly ofU2AF and the prespliceo-somal E complex. Mol Cell 19: 485-496.
46. Timchenko LT, Timchenko NA, Caskey CT, Roberts R. 1996. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy. Hum Mol Genet 5: 115-121.
47. Timchenko NA, Patel R, Iakova P, Cai ZJ, Quan L, Timchenko LT. 2004. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J Biol Chem 279: 13129-13139.
48. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
49. Vlasova IA, Bohjanen PR. 2008. Posttranscriptional regulation of gene networks by GU-rich elements and CELF proteins. RNA Biol 5: 201-207.
50. Vlasova IA, Tahoe NM, Fan D, Larsson O, Rattenbacher B, Sternjohn JR, Vasdewani J, Karypis G, Reilly CS, Bitterman PB, et al. 2008. Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Mol Cell 29: 263-270.
51. Vlasova-St Louis I, Dickson AM, Bohjanen PR, Wilusz CJ. 2013. CELFish ways to modulate mRNA decay. Biochim Biophys Acta 1829: 695-707.
52. Walters R, Parker R. 2014. Quality control: is there quality control of localized mRNAs? J Cell Biol 204: 863-868.
53. Wang Y, Cheong CG, Hall TM, Wang Z. 2009a. Engineering splicing factors with designed specificities. Nat Methods 6: 825-830.
54. Wang Z, Tollervey J, Briese M, Turner D, Ule J. 2009b. CLIP: construction of cDNA libraries for high-throughput sequencing from RNAs cross-linked to proteins in vivo. Methods 48: 287-293.
55. Wang ET, Cody NA, Jog S, Biancolella M, Wang TT, Treacy DJ, Luo S, Schroth GP, Housman DE, Reddy S, et al. 2012. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell 150: 710-724.
56. Ward AJ, Rimer M, Killian JM, Dowling JJ, Cooper TA. 2010. CUGBP1 over-expression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum Mol Genet 19: 3614-3622.
57. Wheeler TM, Lueck JD, Swanson MS, Dirksen RT, Thornton CA. 2007. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J Clin Invest 117: 3952-3957.
58. Xiao X, Wang Z, Jang M, Nutiu R, Wang ET, Burge CB. 2009. Splice site strength-dependent activity and genetic buffering by poly-G runs. Nat Struct Mol Biol 16: 1094-1100.